Listen "PLND, ARPI Switch & De-Escalation | PROSPECT Podcast part 2"
Episode Synopsis
Part 2 Highlights from a GU Cast Live Event! Dr Kim Chi (Medical Oncologist, Vancouver) and Dr Carmen Mir (Urologist, Valencia) joined the PROSPECT meeting in Melbourne to discuss high-risk prostate cancer and mHSPC, along with many experts from around Australia. On the eve of the meeting over dinner, Declan Murphy led a GU Cast-themed panel discussion on five hot topics in prostate cancer, featuring snippets from GU Cast over the past few months.Part 2 today features controversies in PLND, the somewhat notorious ARPI switch control arm beloved of mCRPC trials, and teh importnt topic of de-escalation in advanced prostate cancer. Part 1 recently in your feeds included PSMA conundrums and triplet vs doublet therapy.Even better on our YouTube channelThis is a Themed Podcast supported by our Gold Partners, Johnson & Johnson, who also support the PROSPECT meeting. Special thanks to David Chen for help with videography
More episodes of the podcast GU Cast | Urology Podcast
And in ADDITION....Lu-PSMA improves outcoimes in mHSPC | With Scott Tagawa and Michael Hofman
20/10/2025
Let's talk Common Sense Oncology
19/10/2025
In Taipei for #UAA25
16/10/2025
In Sydney for #ANZUP25
05/10/2025
Journal Club #2 | TRANSLATE and Keynote-564
30/09/2025
Cyberknife - who and what is it good for?
21/09/2025